GW0742 (PPAR-delta agonist)

GW-0742, GW610742

SARMs & research compoundsNot approved for humansWADA S4 · prohibitedEvidence: animal data only

A research PPARδ agonist, not a SARM: a GlaxoSmithKline laboratory tool compound and close relative of cardarine (GW501516); its effects were studied only in cells and animals.

What it gives

What people use it for and what the sources report. Strength is a general category from the literature: mild, clear or strong.

Purpose

Taken for endurance and fat loss, like cardarine, based on mouse studies. It was never approved as a medicine and is sold only as a 'research chemical'.

What people seek and what studies show

In mice it quickly increased the number of oxidative 'endurance' fibres and capillaries in muscle, and together with AICAR and training it extended running time; in diabetic rats it improved insulin sensitivity. In humans there are only lab tests on cells and a single-dose urine study for doping control. Whether it improves endurance or fat loss in people is unknown.

Effects

EnduranceFat loss

Evidence: Animal data only — effects in people are unproven

Sought effects by goal (as reported)

Cutting
Sought for: fat loss
Recomposition
Sought for: fat loss
Endurance
Sought for: endurance, fat loss

Possible side effects

Possible does not mean certain: whether they appear depends on dose, duration, individual response and monitoring. Below — what to watch for and how to notice it early.

6 possible side effects

level · how often it is reported
Elevated
Abnormal tissue growth (theoretical cancer risk)
No long-term cancer studies; its sister GW501516 caused cancers in rodents, and extra PPARδ in blood vessels sped tumour growth in mice.
How to notice: No direct signs — the point is not to fuel existing growths.
rare
Moderate
Black-market quality risk (fakes, contamination)
Unregulated 'research chemical' of unknown purity; in a 2025 UK doping case it came in a 'pre-workout' product from a gym acquaintance.
How to notice: Unexpected effects, pain or infection, a stronger or weaker effect than expected.
common
Moderate
Unknown long-term safety (little human data)
No human safety studies; work in human immune cells and mice points to immune effects, and at high levels it weakly blocks other hormone receptors.
How to notice: Nothing to notice — the risk is what is not yet known.
possible
Moderate
Liver strain
At toxic doses in mice it enlarged the liver and raised liver-injury markers, mostly by also activating PPARα; human data are absent.
How to notice: Usually silent early; later tiredness, nausea, itch, dark urine.
rare
Moderate
Joint & muscle pain
Toxic doses caused muscle damage (myopathy) in mice; unexplained muscle pain or dark urine needs a doctor.
How to notice: Aching or stiff joints, muscle aches.
rare
Low
Heart strain / heart-muscle thickening
In mice heart-muscle cells enlarged within a day, without signs of damage; long-term effects on the heart are unknown.
How to notice: Shortness of breath on effort, lower endurance, palpitations.
rare

What the levels mean

Lowbackground — just be aware
Moderatewatch for signs
Elevatedneeds regular control
Highcritical — can be life-threatening or permanent

Level: general category from the literature, not your personal risk

How often

common
reported often
possible
reported in some people
rare
reported occasionally

How to lower the risks

For 3 of 6 possible side effects there are specific ways to lower the chance: everyday measures, supplements and options a doctor may consider. For the rest — general advice. No measure removes a risk completely.

ElevatedAbnormal tissue growth (theoretical cancer risk)

No check-up or blood test lowers this risk; avoid with any personal or family history of cancer.

ModerateBlack-market quality risk (fakes, contamination)

Products obtained without a prescription are often fake, mislabeled or non-sterile, and there is no way to check at home. For legal supplements, look for third-party testing (Informed Sport, NSF).

ModerateUnknown long-term safety (little human data)

What is unknown cannot be lowered, only avoided; tell your doctor what you have taken.

ModerateLiver strain

No alcohol, no other liver stressors, limit oral steroids and their combinations, check liver enzymes.

Measure
Avoiding alcohol and other liver stressorsRegular blood tests
How each option helps (5)
  • Avoiding alcohol and other liver stressors — Removes a major extra liver stressor during oral steroids and other hepatotoxic drugs.
  • Regular blood tests — ALT, AST, GGT and bilirubin show liver strain before symptoms; heavy lifting alone raises AST/ALT for days, and GGT helps tell muscle from liver.
  • Ademetionine (SAMe) — Used for intrahepatic cholestasis in some countries, but trials are small and of low quality; untested in steroid users. Stopping the oral steroid matters most.
  • N-acetylcysteine (NAC) — Restores glutathione; proven in paracetamol poisoning and helped in early acute liver failure of other causes, but untested in steroid users.
  • TUDCA (tauroursodeoxycholic acid) — Improves bile flow in cholestatic disease; in steroid cholestasis only case reports, with failures in severe cases. Stopping the oral steroid matters most.
ModerateJoint & muscle pain

Check estradiol (too low hurts joints), warm up well, avoid overloading.

Measure
Working with a doctor
Supplement or OTC product
How each option helps (2)
  • Working with a doctor — Finds the cause of joint or muscle pain — estradiol pushed too low by an aromatase inhibitor, GH-driven swelling, statin muscle effects — so treatment can be adjusted.
  • Coenzyme Q10 — May ease statin-related muscle aches (one meta-analysis positive, results mixed); no help for joint pain from low estrogen.

Low-level side effects

Heart
Regular cardio, blood pressure control, an echo as a baseline and then yearly.
Measure
Heart screening: ECG and echocardiogramWorking with a doctorHome blood-pressure monitoringRegular cardio training
How each option helps (4)
  • Heart screening: ECG and echocardiogram — Echocardiography shows wall thickening and reduced pumping early, while stopping AAS and treating BP can still help.
  • Working with a doctor — Orders ECG and echocardiography and treats early heart changes.
  • Home blood-pressure monitoring — Keeping BP controlled is one of the main ways to limit heart-wall thickening.
  • Regular cardio training — Supports heart and vessel function, but does not reverse steroid-related heart thickening or weakening.

Check-ups and blood tests

Which tests and check-ups to do and when. This is a guide — agree the exact schedule with your doctor.

Baseline tests
your own starting values — every later result is compared with them
Liver panel (ALT, AST, GGT, bilirubin)liver
While taking
about 4–6 weeks in, then every 6–8 weeks — agree the exact schedule with your doctor
Liver panel (ALT, AST, GGT, bilirubin)liver
After stopping
4–8 weeks after stopping (later after long-acting injections), then until values return to baseline
Liver panel (ALT, AST, GGT, bilirubin)liver

Which doctors can help

Gastroenterologist / hepatologistliver
Sports physicianjoints & muscles

Get medical help at once if

  • A new lump (including in the neck), trouble swallowing or persistent hoarseness, unexplained weight loss, or blood in stool or urine — see a doctor promptly.
  • Yellow skin or eyes, dark urine, pale stools, intense itching, pain under the right ribs — see a doctor now; sudden severe abdominal pain with dizziness or fainting — call emergency services.

In an emergency, call your local emergency number.

For women

Non-hormonal, so no virilization is expected, but there are no safety data in women, including in pregnancy.

Myth & fact

Myth

“GW0742 is a safer version of cardarine.”

Fact

Nothing shows that. It acts on the same receptor, has never been tested for safety in humans, and its sister compound was dropped after causing cancers in rodents.

Combinations

OverlapGW0742 with cardarine

Both activate the same receptor, PPAR-delta, so the second adds no known benefit. Cardarine's development was stopped after long-term animal studies found cancers; GW0742 acts the same way and was never tested for this, so together they only add exposure to that pathway.

Cardarine (GW501516)

Check combinations →

Similar substances